"Federal Scientists Advocate Marijuana Reclassification for Medical Use"
The Department of Health and Human Services released a 252-page review recommending the loosening of federal restrictions on marijuana, citing credible evidence of its medical benefits and lower potential for abuse compared to other scheduled drugs. This marks a significant departure from the federal government's longstanding classification of cannabis as a Schedule I drug. The review, conducted at the request of President Joe Biden, recommends moving marijuana to Schedule III, with the final decision resting with the Drug Enforcement Administration. The review also found that marijuana has a lower public health risk and potential for abuse than other scheduled drugs, based on scientific criteria and analysis of various medical conditions.
- Federal scientists conclude there is credible evidence for certain medical uses of marijuana POLITICO
- Federal Scientists Recommend Easing Restrictions on Marijuana The New York Times
- Marijuana meets criteria for reclassification as lower-risk drug, FDA scientific review finds CNN
- Colorado’s attorney general leads call for DEA to reschedule marijuana The Denver Post
- Marijuana reclassification proposed over lower public health risk, documents show The Washington Post
Want the full story? Read the original reporting
Read on POLITICO